{"slug":"api-magentlab-com-api-calc-prevent-3c6a07","title":"Khan 2024 AHA PREVENT base 10-year total CVD percent (ASCVD plus heart failure) ","host":"api.magentlab.com","method":"GET","resource":"https://api.magentlab.com/api/calc/prevent","category":"other","description":"Khan 2024 AHA PREVENT base 10-year total CVD percent (ASCVD plus heart failure) for age 30-79 from sex, lipids, treated systolic BP, diabetes, smoking, eGFR, BMI, antihypertensive, and statin. Sex-specific, race-free Table S12 coefficients. Not 30-year, not ASCVD-only, not HF-only, not 2013 PCE, not","price_listed":0.005,"price_asked":0.005,"state":"answering","state_label":"Answering","checks_7d":1,"answered_7d":1,"latency_ms_median":316,"reported_calls_30d":0,"reported_payers_30d":0,"networks":["eip155:8453"],"badge":"unverified","paid_checks_7d":0,"paid_ok_7d":0,"example_input":{"method":"GET","queryParams":{"age":50,"antihypertensive":true,"bmi_kg_m2":35,"diabetes":false,"egfr_ml_min_1_73m2":90,"hdl_mg_dl":55,"sbp_mm_hg":160,"sex":"female","smoker":false,"statin":false,"total_cholesterol_mg_dl":240},"type":"http"},"output_schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"enum":["GET","HEAD","DELETE"],"type":"string"},"queryParams":{"properties":{"age":{"description":"Age in years (integer 30-79). Khan 2024 PREVENT base 10-year total CVD is for ages 30-79. Not 30-year PREVENT (that horizon is not returned).","type":"integer"},"antihypertensive":{"description":"Current antihypertensive treatment as assigned by the caller (true or false). Adds the Table S12 antihypertensive term and the treated SBP interaction.","type":"boolean"},"bmi_kg_m2":{"description":"Body-mass index in kg/m2 (10-80). Required Khan 2024 predictor. Table S12 base 10-year total-CVD BMI coefficients are 0 (BMI enters the HF-only equations, which this tool does not return).","type":"number"},"diabetes":{"description":"Diabetes as assigned by the caller (true or false). Adds the Table S12 diabetes term and the age × diabetes interaction. Not the optional HbA1c add-on equation.","type":"boolean"},"egfr_ml_min_1_73m2":{"description":"Caller-assigned eGFR in mL/min/1.73m2 (5-200). Piecewise around 60. magent does not compute MDRD or CKD-EPI.","type":"number"},"hdl_mg_dl":{"description":"HDL cholesterol in mg/dL (5-150). Converted as mg/dL*0.02586 to mmol/L. Enters as (HDL-1.3)/0.3. magent does not assay lipids.","type":"number"},"sbp_mm_hg":{"description":"Systolic blood pressure in mm Hg (50-250). Piecewise around 110 mm Hg, with a treated-SBP interaction when antihypertensive is true. magent does not measure blood pressure.","type":"number"},"sex":{"description":"Sex used by the sex-specific Table S12 base 10-year total-CVD coefficients (female or male). Not race. PREVENT is race-free.","enum":["female","male"],"type":"string"},"smoker":{"description":"Current cigarette smoking as assigned by the caller (true or false). magent does not take a smoking history.","type":"boolean"},"statin":{"description":"Current statin use as assigned by the caller (true or false). Adds the Table S12 statin term and the statin × non-HDL interaction.","type":"boolean"},"total_cholesterol_mg_dl":{"description":"Total cholesterol in mg/dL (50-800). Converted as mg/dL*0.02586 to mmol/L. Enters as non-HDL (TC-HDL) centered at 3.5 mmol/L. magent does not assay lipids.","type":"number"}},"required":["age","sex","total_cholesterol_mg_dl","hdl_mg_dl","sbp_mm_hg","antihypertensive","statin","diabetes","smoker","egfr_ml_min_1_73m2","bmi_kg_m2"],"type":"object"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"},"history":[{"day":"2026-09-28","reachable":true,"status":402,"valid_402":true,"asked_usdc":0.005,"price_match":true,"latency_ms":316,"error":null}],"description_full":"Khan 2024 AHA PREVENT base 10-year total CVD percent (ASCVD plus heart failure) for age 30-79 from sex, lipids, treated systolic BP, diabetes, smoking, eGFR, BMI, antihypertensive, and statin. Sex-specific, race-free Table S12 coefficients. Not 30-year, not ASCVD-only, not HF-only, not 2013 PCE, not SCORE2, not a diagnosis or statin order. magent does not assay lipids.","last_updated":"2026-09-28T12:42:10.06Z","schemes":["batch-settlement","exact"]}